These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15921860)

  • 21. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
    Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
    Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.
    Poirier R; Wolfer DP; Welzl H; Tracy J; Galsworthy MJ; Nitsch RM; Mohajeri MH
    Neurobiol Dis; 2006 Dec; 24(3):475-83. PubMed ID: 17008108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
    Rofo F; Ugur Yilmaz C; Metzendorf N; Gustavsson T; Beretta C; Erlandsson A; Sehlin D; Syvänen S; Nilsson P; Hultqvist G
    Theranostics; 2021; 11(2):789-804. PubMed ID: 33391505
    [No Abstract]   [Full Text] [Related]  

  • 27. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
    Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR
    J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.
    Mouri A; Zou LB; Iwata N; Saido TC; Wang D; Wang MW; Noda Y; Nabeshima T
    Behav Brain Res; 2006 Mar; 168(1):83-91. PubMed ID: 16360221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol trafficking and amyloid beta peptides.
    Wood WG; Igbavboa U
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ; Zhou HD; Zhou XF
    Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Presymptomatic diagnosis, prevention and therapy].
    Iwata N; Higuchi M; Saito T; Saido TC
    No To Shinkei; 2005 Oct; 57(10):855-66. PubMed ID: 16277230
    [No Abstract]   [Full Text] [Related]  

  • 34. Minocycline prevents Abeta(25-35)-induced reduction of somatostatin and neprilysin content in rat temporal cortex.
    Burgos-Ramos E; Puebla-Jiménez L; Arilla-Ferreiro E
    Life Sci; 2009 Feb; 84(7-8):205-10. PubMed ID: 19101571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Towards presymptomatic diagnosis, prevention and treatment of Alzheimer's disease].
    Saido TC
    Rinsho Shinkeigaku; 2004 Nov; 44(11):775-7. PubMed ID: 15651288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise your amyloid.
    Karsten SL; Geschwind DH
    Cell; 2005 Mar; 120(5):572-4. PubMed ID: 15766520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neprilysin protects human neuronal progenitor cells against impaired development caused by amyloid-beta peptide.
    Mazur-Kolecka B; Frackowiak J
    Brain Res; 2006 Dec; 1124(1):10-8. PubMed ID: 17112488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.